Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 12.27B | 11.72B | 11.82B | 12.69B | 11.61B | 12.02B |
Gross Profit | 12.16B | 11.14B | 11.82B | 11.52B | 12.50B | 12.14B |
EBITDA | 2.31B | 1.77B | 2.31B | 2.40B | 2.30B | 2.43B |
Net Income | 1.33B | 1.33B | 1.25B | 1.28B | 1.20B | 990.00M |
Balance Sheet | ||||||
Total Assets | 851.06B | 851.06B | 876.89B | 895.00B | 970.15B | 963.50B |
Cash, Cash Equivalents and Short-Term Investments | 35.32B | 35.32B | 72.28B | 72.49B | 135.22B | 166.10B |
Total Debt | 4.50B | 4.50B | 40.22B | 50.65B | 114.29B | 105.34B |
Total Liabilities | 818.35B | 818.35B | 838.38B | 858.23B | 930.51B | 922.75B |
Stockholders Equity | 31.84B | 31.84B | 37.64B | 35.91B | 38.77B | 39.91B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 5.38B | -10.18B | -93.42B | -34.14B | 113.18B |
Operating Cash Flow | 0.00 | 5.57B | -9.11B | -92.83B | -33.87B | 113.44B |
Investing Cash Flow | 0.00 | -18.74B | 9.42B | 31.35B | 4.58B | 2.13B |
Financing Cash Flow | 0.00 | -23.73B | -6.89B | -384.00M | -378.00M | -378.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥10.14B | 7.15 | 4.01% | 2.44% | 10.20% | ||
73 Outperform | ¥12.69B | 9.82 | 3.71% | 9.46% | 9.41% | ||
73 Outperform | ¥12.19B | 6.94 | 1.10% | 2.20% | ― | ||
72 Outperform | ¥12.89B | 11.15 | 3.68% | 7.67% | -26.27% | ||
68 Neutral | $17.80B | 11.94 | 9.89% | 3.74% | 9.69% | 1.17% | |
61 Neutral | ¥9.14B | 8.74 | 2.99% | -9.75% | 81.65% | ||
57 Neutral | ¥8.58B | ― | 2.02% | 2.60% | -246.98% |